. | . | . | . | Sample collection . | . | |
---|---|---|---|---|---|---|
Patient . | Clinical findings at birth . | Antiviral regime . | Clinical findings at follow-up . | Time point . | Compartment . | Viral load (IU/mL) . |
1 | Poor motility, germinolysis | None | No symptoms | 0 M | Saliva | 2.6 × 109 |
3 M | Blooda | 2.5 × 101 | ||||
Saliva | NE | |||||
Urine | 4.0 × 106 | |||||
6 M | Blooda | 2.1 × 102 | ||||
Saliva | NE | |||||
Urine | 2.8 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Saliva | NE | |||||
Urine | 9.6 × 105 | |||||
2 | IUGR, low platelet count, hepatitis, poor motility | GCV, vGCV | SNHL, hypotonia, tremors | 0 M | Blood | 2.7 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 6.9 × 106 | |||||
3 M | Blooda | 1.2 × 101 | ||||
Saliva | 7.2 × 109 | |||||
Urine | 8.4 × 106 | |||||
6 M | Blooda | 1.2 × 102 | ||||
Saliva | NE | |||||
Urine | 4.1 × 105 | |||||
12 M | Blooda | 2.4 × 101 | ||||
Saliva | NE | |||||
Urine | 1.5 × 103 | |||||
3 | Asymptomatic | None | No symptoms | 0 M | Blood | 8.4 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 5.2 × 106 | |||||
3 M | Blood | 2.2 × 102 | ||||
Saliva | NE | |||||
Urine | 2.3 × 106 | |||||
6 M | Blooda | 8.7 × 101 | ||||
Saliva | NE | |||||
Urine | 6.2 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Salivaa | NE |
. | . | . | . | Sample collection . | . | |
---|---|---|---|---|---|---|
Patient . | Clinical findings at birth . | Antiviral regime . | Clinical findings at follow-up . | Time point . | Compartment . | Viral load (IU/mL) . |
1 | Poor motility, germinolysis | None | No symptoms | 0 M | Saliva | 2.6 × 109 |
3 M | Blooda | 2.5 × 101 | ||||
Saliva | NE | |||||
Urine | 4.0 × 106 | |||||
6 M | Blooda | 2.1 × 102 | ||||
Saliva | NE | |||||
Urine | 2.8 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Saliva | NE | |||||
Urine | 9.6 × 105 | |||||
2 | IUGR, low platelet count, hepatitis, poor motility | GCV, vGCV | SNHL, hypotonia, tremors | 0 M | Blood | 2.7 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 6.9 × 106 | |||||
3 M | Blooda | 1.2 × 101 | ||||
Saliva | 7.2 × 109 | |||||
Urine | 8.4 × 106 | |||||
6 M | Blooda | 1.2 × 102 | ||||
Saliva | NE | |||||
Urine | 4.1 × 105 | |||||
12 M | Blooda | 2.4 × 101 | ||||
Saliva | NE | |||||
Urine | 1.5 × 103 | |||||
3 | Asymptomatic | None | No symptoms | 0 M | Blood | 8.4 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 5.2 × 106 | |||||
3 M | Blood | 2.2 × 102 | ||||
Saliva | NE | |||||
Urine | 2.3 × 106 | |||||
6 M | Blooda | 8.7 × 101 | ||||
Saliva | NE | |||||
Urine | 6.2 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Salivaa | NE |
Sequencing library not generated.
Abbreviations: 0 M, within 3 weeks; 3 M, 3 months; 6 M, 6 months; 12 M, 12 months; GCV, ganciclovir; vGCV, valganciclovir; IUGR, intrauterine growth restriction; SNHL, sensorineural hearing loss; NE, viral load not estimated.
. | . | . | . | Sample collection . | . | |
---|---|---|---|---|---|---|
Patient . | Clinical findings at birth . | Antiviral regime . | Clinical findings at follow-up . | Time point . | Compartment . | Viral load (IU/mL) . |
1 | Poor motility, germinolysis | None | No symptoms | 0 M | Saliva | 2.6 × 109 |
3 M | Blooda | 2.5 × 101 | ||||
Saliva | NE | |||||
Urine | 4.0 × 106 | |||||
6 M | Blooda | 2.1 × 102 | ||||
Saliva | NE | |||||
Urine | 2.8 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Saliva | NE | |||||
Urine | 9.6 × 105 | |||||
2 | IUGR, low platelet count, hepatitis, poor motility | GCV, vGCV | SNHL, hypotonia, tremors | 0 M | Blood | 2.7 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 6.9 × 106 | |||||
3 M | Blooda | 1.2 × 101 | ||||
Saliva | 7.2 × 109 | |||||
Urine | 8.4 × 106 | |||||
6 M | Blooda | 1.2 × 102 | ||||
Saliva | NE | |||||
Urine | 4.1 × 105 | |||||
12 M | Blooda | 2.4 × 101 | ||||
Saliva | NE | |||||
Urine | 1.5 × 103 | |||||
3 | Asymptomatic | None | No symptoms | 0 M | Blood | 8.4 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 5.2 × 106 | |||||
3 M | Blood | 2.2 × 102 | ||||
Saliva | NE | |||||
Urine | 2.3 × 106 | |||||
6 M | Blooda | 8.7 × 101 | ||||
Saliva | NE | |||||
Urine | 6.2 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Salivaa | NE |
. | . | . | . | Sample collection . | . | |
---|---|---|---|---|---|---|
Patient . | Clinical findings at birth . | Antiviral regime . | Clinical findings at follow-up . | Time point . | Compartment . | Viral load (IU/mL) . |
1 | Poor motility, germinolysis | None | No symptoms | 0 M | Saliva | 2.6 × 109 |
3 M | Blooda | 2.5 × 101 | ||||
Saliva | NE | |||||
Urine | 4.0 × 106 | |||||
6 M | Blooda | 2.1 × 102 | ||||
Saliva | NE | |||||
Urine | 2.8 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Saliva | NE | |||||
Urine | 9.6 × 105 | |||||
2 | IUGR, low platelet count, hepatitis, poor motility | GCV, vGCV | SNHL, hypotonia, tremors | 0 M | Blood | 2.7 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 6.9 × 106 | |||||
3 M | Blooda | 1.2 × 101 | ||||
Saliva | 7.2 × 109 | |||||
Urine | 8.4 × 106 | |||||
6 M | Blooda | 1.2 × 102 | ||||
Saliva | NE | |||||
Urine | 4.1 × 105 | |||||
12 M | Blooda | 2.4 × 101 | ||||
Saliva | NE | |||||
Urine | 1.5 × 103 | |||||
3 | Asymptomatic | None | No symptoms | 0 M | Blood | 8.4 × 104 |
Saliva | 2.4 × 108 | |||||
Urine | 5.2 × 106 | |||||
3 M | Blood | 2.2 × 102 | ||||
Saliva | NE | |||||
Urine | 2.3 × 106 | |||||
6 M | Blooda | 8.7 × 101 | ||||
Saliva | NE | |||||
Urine | 6.2 × 106 | |||||
12 M | Blooda | 1.2 × 101 | ||||
Salivaa | NE |
Sequencing library not generated.
Abbreviations: 0 M, within 3 weeks; 3 M, 3 months; 6 M, 6 months; 12 M, 12 months; GCV, ganciclovir; vGCV, valganciclovir; IUGR, intrauterine growth restriction; SNHL, sensorineural hearing loss; NE, viral load not estimated.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.